October 17, 2018
Pfizer Inc. is recalling 7777 bottles of Glipizide XL (glipizide) extended-release tablets, 5 mg (NDC 59762-0541-2). According to the October 17, 2018, US Food and Drug Administration (FDA) Enforcement Report, rejected product was used during manufacturing of the now-recalled lot.
The recall is for 500-tablet bottles from lot T71137 (Exp. 2/22). The bottles were distributed by Greenstone LLC throughout the United States.
Pfizer voluntarily initiated the recall September 20, 2018. On October 9, 2018, the FDA designated it Class II. Use of products under a Class II recall could cause temporary or medically reversible harm, or a remote possibility of serious harm.
Glipizide XL is a prescription medication used to improve glycemic control in people with type 2 diabetes.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here